Tumor Biology

, Volume 36, Issue 5, pp 3171–3177 | Cite as

Role of pancreatic stellate cells and periostin in pancreatic cancer progression

Review

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and one of the five most lethal malignancies characterized by prominent desmoplastic reaction. Accumulating evidences indicate that tumor desmoplasia plays a pivotal role in PDAC progression, and it has been largely ignored until recent times. It has now been unequivocally shown that pancreatic stellate cells (PSCs) are the principal effector cells responsible for stroma production. Periostin, also known as osteoblast-specific factor 2, is a secretory protein and originally identified as an osteoblast-specific factor that expressed in periosteum. Periostin is exclusively produced by activated PSCs, and periostin overexpression presents in various malignant tumors and closely relates with disease progression. In addition, periostin has been suggested to stimulate pancreatic cancer cells proliferation and enhance their resistance to serum starvation and hypoxia. Therefore, the interplay between cancer cells and stromal cells plays a vital role in PDAC development. However, the function of periostin in pancreatic cancer development is controversial. This review summarizes existing knowledge about the role of PSCs in cancer stroma production, the interaction between PSCs and pancreatic cancer cells, tumor angiogenesis, and hypoxic microenvironment, with particular focus on the expression and function as well as signaling pathways of periostin in PDAC cells and PSCs.

Keywords

Periostin Pancreatic stellate cells Pancreatic ductal adenocarcinoma Stroma Extracellular matrix 

References

  1. 1.
    Viale A. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature. 2014;514:628–32.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Xu Z. Pancreatic cancer and its stroma: a conspiracy theory. World J Gastroenterol. 2014;20:11216–29.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Erkan M. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9:454–67.CrossRefPubMedGoogle Scholar
  4. 4.
    Bachem MG. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology. 2005;128:907–21.CrossRefPubMedGoogle Scholar
  5. 5.
    Erkan M. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol. 2008;6:1155–61.CrossRefPubMedGoogle Scholar
  6. 6.
    Wilson JS. Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression. Front Physiol. 2014;5:52.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Duner S. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression. Pancreatology. 2010;10:673–81.CrossRefPubMedGoogle Scholar
  8. 8.
    Haqq J. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies. Eur J Cancer. 2014;50:2570–82.CrossRefPubMedGoogle Scholar
  9. 9.
    Haage A, Schneider IC. Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells. FASEB J. 2014;28:3589–99.CrossRefPubMedGoogle Scholar
  10. 10.
    Takeshita S. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 1993;294(Pt 1):271–8.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Ruan K. The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci. 2009;66:2219–30.CrossRefPubMedGoogle Scholar
  12. 12.
    Ben QW. Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer. Oncol Rep. 2011;25:709–16.PubMedGoogle Scholar
  13. 13.
    Erkan M. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology. 2007;132:1447–64.CrossRefPubMedGoogle Scholar
  14. 14.
    Xu D. Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer. PLoS One. 2012;7:e46670.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Morra L. Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer. 2012;76:183–90.CrossRefPubMedGoogle Scholar
  16. 16.
    Sasaki H. Expression of the periostin mRNA level in neuroblastoma. J Pediatr Surg. 2002;37:1293–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Baril P. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene. 2007;26:2082–94.CrossRefPubMedGoogle Scholar
  18. 18.
    Merle B, Garnero P. The multiple facets of periostin in bone metabolism. Osteoporos Int. 2012;23:1199–212.CrossRefPubMedGoogle Scholar
  19. 19.
    Conway SJ. The inter-relationship of periostin, TGF beta, and BMP in heart valve development and valvular heart diseases. Sci World J. 2011;11:1509–24.CrossRefGoogle Scholar
  20. 20.
    Romanos GE. PERIOSTIN: role in formation and maintenance of dental tissues. J Cell Physiol. 2014;229:1–5.PubMedGoogle Scholar
  21. 21.
    Rios H. periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol. 2005;25:11131–44.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Tkatchenko TV. Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiol Genomics. 2009;39:160–8.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Lie-Venema H. Periostin expression by epicardium-derived cells is involved in the development of the atrioventricular valves and fibrous heart skeleton. Differentiation. 2008;76:809–19.CrossRefPubMedGoogle Scholar
  24. 24.
    Zhao S. Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. J Cardiol. 2014;63:373–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Stansfield WE. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart. Ann Thorac Surg. 2009;88:1916–21.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Li J. [Roles of periostin in proliferation and migration of vascular smooth muscle cells and the effect of atorvastatin on them]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37:689–94.PubMedGoogle Scholar
  27. 27.
    Rani S. Induction of periostin-like factor and periostin in forearm muscle, tendon, and nerve in an animal model of work-related musculoskeletal disorder. J Histochem Cytochem. 2009;57:1061–73.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Goetsch SC. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol Genomics. 2003;14:261–71.CrossRefPubMedGoogle Scholar
  29. 29.
    Rousseau JC. Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study. J Clin Endocrinol Metab. 2014;99:2533–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Nuzzo PV. Periostin: a novel prognostic and therapeutic target for genitourinary cancer? Clin Genitourin Cancer. 2014;12:301–11.CrossRefPubMedGoogle Scholar
  31. 31.
    Gillan L. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha (V) beta (3) and alpha (V) beta (5) integrins and promotes cell motility. Cancer Res. 2002;62:5358–64.PubMedGoogle Scholar
  32. 32.
    Kim CJ. Role of alternative splicing of periostin in human bladder carcinogenesis. Int J Oncol. 2008;32:161–9.PubMedGoogle Scholar
  33. 33.
    Apte MV. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut. 1998;43:128–33.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Apte MV. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas. 2004;29:179–87.CrossRefPubMedGoogle Scholar
  35. 35.
    Heinemann V. Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies. Cancer Treat Rev. 2014;40:118–28.CrossRefPubMedGoogle Scholar
  36. 36.
    Yoshitomi H. Specific expression of endoglin (CD105) in endothelial cells of intratumoral blood and lymphatic vessels in pancreatic cancer. Pancreas. 2008;37:275–81.CrossRefPubMedGoogle Scholar
  37. 37.
    Froeling FE. Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, beta-catenin, and Ezrin expression in tumor cells. Am J Pathol. 2009;175:636–48.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Vonlaufen A. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 2008;68:2085–93.CrossRefPubMedGoogle Scholar
  39. 39.
    Hwang RF. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68:918–26.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Erkan M. Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma. Neoplasia. 2009;11:497–508.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Gemcitabine plus bevacizumab no better than gemcitabine alone in clinical study of 600 patients with pancreatic cancer. Cancer Biol Ther. 2007;6:137.Google Scholar
  42. 42.
    Reiser-Erkan C. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther. 2008;7:1352–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Couvelard A. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology. 2005;46:668–76.CrossRefPubMedGoogle Scholar
  44. 44.
    Erkan M. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut. 2012;61:172–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Kanno A. Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells. Int J Cancer. 2008;122:2707–18.CrossRefPubMedGoogle Scholar
  46. 46.
    Conway SJ. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci. 2014;71:1279–88.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  1. 1.Department of Ultrasound, Shanghai First People’s Hospital, School of MedicineShanghai Jiaotong UniversityShanghaiPeople’s Republic of China

Personalised recommendations